Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Cognitive Symptoms in PD and MSA
NCT02064166Phase 2Completed
- Start
- Feb 2014
- Primary completion
- Sep 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of intranasal insulin in Parkinson's disease (PD), multiple system atrophy (MSA). Started Feb 2014; status: completed.
02
Drugs
intranasal insulin
03
Conditions
Parkinson's disease (PD)multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT02064166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02064166.